# Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation

> **NCT01839721** · PHASE3 · COMPLETED · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 246 (actual)

## Conditions studied

- Cancer
- Diarrhea
- Abdominal Pain
- Quality of Life

## Interventions

- **DRUG:** Bifilact®
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01839721
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2013-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01839721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01839721, "Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01839721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*